Last reviewed · How we verify
STAHIST NDC #58407-536-01 — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
STAHIST NDC #58407-536-01 (STAHIST NDC #58407-536-01) — Magna Pharmaceuticals, Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| STAHIST NDC #58407-536-01 TARGET | STAHIST NDC #58407-536-01 | Magna Pharmaceuticals, Inc. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- STAHIST NDC #58407-536-01 CI watch — RSS
- STAHIST NDC #58407-536-01 CI watch — Atom
- STAHIST NDC #58407-536-01 CI watch — JSON
- STAHIST NDC #58407-536-01 alone — RSS
Cite this brief
Drug Landscape (2026). STAHIST NDC #58407-536-01 — Competitive Intelligence Brief. https://druglandscape.com/ci/stahist-ndc-58407-536-01. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab